ImClone says it has mystery suitor
September 12th, 2008 by 
admin ImClone yesterday formally unloved a $60-per-share substance from Bristol-Myers Squibb to acquire the 83 per coin of the consort it does not already own, and countered…
Posted in Pharmaceuticals | 